Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world's biggest drug developers are tapping into the growing treatment market.
Nov 16, 2023
0
0
COVID-19 is the most extensive and consequential epidemic in nearly a century. The number of genomic sequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) far exceeds the sum of sequences of other ...
Nov 14, 2023
0
1
A new element of the catastrophic impacts of climate change is emerging—how global warming is impacting the human brain.
Nov 13, 2023
0
36
Arguments are still raging about how humanity could have been better prepared for COVID-19. Indeed, politicians who chose different approaches to handling the emerging viral pandemic and especially those who had abandoned ...
Nov 9, 2023
0
0
Global warming caused by climate change could exacerbate the burden of inpatient mortality from respiratory diseases during the warm season. This is the main conclusion of a study led by the Barcelona Institute for Global ...
Nov 7, 2023
0
12
Cardiovascular diseases are a leading cause of death globally, particularly in the developed countries. Atherosclerosis, which is characterized by a gradual build-up of plaque in the walls of arteries, is a serious cardiovascular ...
Nov 2, 2023
0
12
The COVID-19 pandemic has changed the way we think about health and revealed significant flaws within our health care systems. It has also raised questions about the role of technology, as well as ethical concerns about the ...
Nov 2, 2023
0
1
Traditional disease-monitoring systems are ill-equipped to handle the recent unprecedented outbreaks of climate-aggravated diseases. In a viewpoint article published in Science Translational Medicine, SFI's Samuel Scarpino ...
Oct 31, 2023
0
0
The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in 2019. This raises the ...
Oct 27, 2023
0
53
Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement ...
Oct 26, 2023
0
1
